about

WE'RE A LITTLE BIT DIFFERENT

AND YOU'RE REALLY GOING TO LIKE THAT!

Recruiters are pretty awesome!

  • We give you access to candidates you won’t find on your own.
  • We recruit from places you can’t…like your direct competitors.
  • We provide market expertise, so you can make the right hire, faster.

HirePerfect is like other recruiters, only better.

  • We find great talent (seriously, we can find a needle in a haystack).
  • We’re woman owned (yay diversity!).
  • We give back to the community (making a difference matters).

But the big difference is that we charge a lot less!

Our one-of-a-kind service model means you only pay for the recruiting support you need.  Whether you need candidate sourcing or prefer flat-fee recruiting, we offer the service you want – with 100% guaranteed results.

LEARN MORE ABOUT HIREPERFECT SERVICES

Our Mission

Turning the old recruiting model on its head – by providing access to high-demand talent – without demanding a high premium.

Our Vision is to create a revolution in the recruiting industry. With our three awesome recruiting options, our clients can do more than hire better…they can HirePerfect.

CHECK OUT OUR SPECIALTIES
CONTACT US FOR RECRUITING SERVICES

HEY RECRUITERS!

Want to work for a super-awesome firm?

We’re looking for talented, experienced people like you! Tell us your recruiting niche, what kind of people you recruit, where you are located and how awesome you are at your job. Then come help us shake up traditional recruiting.

Our primary markets:

  • Greater Boston Area
  • New York/Northern New Jersey
  • Philadelphia
  • Raleigh-Durham
  • San Diego/Southern California
  • San Francisco
  • Tampa/Southwest Florida

We extend our services to organizations nationwide.

Is your region not listed? Contact us for help.

Don't Hire Better, HirePerfect.

What's New?

  • Four Tips for Raising Capital for your BioTech Startup

    The coming year looks like it could be a good one for biotechnology startups. In recent years, biotech has had reasonably good access to capital as interest has increased in development of new medicines for cancer and “orphan” diseases. While access to investor funds may not be easy in 2016, few expect a return to […]

View All News